BioAmber Inc.
BIOA
BIOA was delisted on the 8th of February, 2018.
19 hedge funds and large institutions have $41.2M invested in BioAmber Inc. in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
51% more capital invested
Capital invested by funds: $27.3M → $41.2M (+$13.9M)
27% more funds holding
Funds holding: 15 → 19 (+4)
0.35% less ownership
Funds ownership: 30.23% → 29.88% (-0.35%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
+$1.14M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$882K |
| 3 |
RA
Royce & Associates
New York
|
+$719K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$163K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$158K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.61M |
| 2 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$610K |
| 3 |
Millennium Management
New York
|
-$603K |
| 4 |
SCM
Saba Capital Management
New York
|
-$196K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$177K |
BIOA Hedge Fund Activity: Q4 2013 in Review
19 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q4 2013, worth a combined $41.2M — up 51% from $27.3M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new BIOA positions and 2 closed out — a net gain of 4 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Levin Capital Strategies, adding an estimated $1.14M. The largest seller was Credit Suisse, cutting an estimated $1.61M.
- 19 institutional investors held BioAmber Inc. (BIOA) as of Q4 2013, up from 15 in Q3 2013.
- Funds reported $41.2M of BioAmber Inc. stock for Q4 2013, up 51% quarter-over-quarter.
- 6 funds opened new BioAmber Inc. positions in Q4 2013 and 2 closed out, a net change of +4 holders.
- The largest BioAmber Inc. buyer in Q4 2013 was Levin Capital Strategies, an estimated $1.14M added.
- The largest BioAmber Inc. seller in Q4 2013 was Credit Suisse, an estimated $1.61M sold.
Based on aggregated 13F filings for Q4 2013.